Your browser doesn't support javascript.
loading
Development of reference material with assigned value for human T-cell leukemia virus type 1 quantitative PCR in Japan.
Kuramitsu, Madoka; Okuma, Kazu; Nakashima, Makoto; Sato, Tomoo; Sasaki, Daisuke; Hasegawa, Hiroo; Umeki, Kazumi; Kubota, Ryuji; Sasada, Keiko; Sobata, Rieko; Matsumoto, Chieko; Kaneko, Noriaki; Tezuka, Kenta; Matsuoka, Sahoko; Utsunomiya, Atae; Koh, Ki-Ryang; Ogata, Masao; Ishitsuka, Kenji; Taki, Mai; Nosaka, Kisato; Uchimaru, Kaoru; Iwanaga, Masako; Sagara, Yasuko; Yamano, Yoshihisa; Okayama, Akihiko; Miura, Kiyonori; Satake, Masahiro; Saito, Shigeru; Watanabe, Toshiki; Hamaguchi, Isao.
Afiliação
  • Kuramitsu M; Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan.
  • Okuma K; Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan.
  • Nakashima M; Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.
  • Sato T; Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki, Japan.
  • Sasaki D; Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
  • Hasegawa H; Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
  • Umeki K; Department of Rheumatology, Infectious Diseases and Laboratory Medicine, University of Miyazaki, Miyazaki, Japan.
  • Kubota R; Division of Molecular Pathology, Center for Chronic Viral Diseases, Kagoshima University, Kagoshima, Japan.
  • Sasada K; Department of Laboratory Medicine, Kumamoto University Hospital, Kumamoto, Japan.
  • Sobata R; Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan.
  • Matsumoto C; Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan.
  • Kaneko N; Department of Infection and Immunology, SRL Inc., Tokyo, Japan.
  • Tezuka K; Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan.
  • Matsuoka S; Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan.
  • Utsunomiya A; Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
  • Koh KR; Department of Hematology, Osaka General Hospital of West Japan Railway Company, Osaka, Japan.
  • Ogata M; Department of Hematology, Oita University Hospital, Oita, Japan.
  • Ishitsuka K; Division of Hematology and Immunology, Center for Chronic Viral Diseases, Kagoshima University, Kagoshima, Japan.
  • Taki M; Rakuwakai Kyoto Medical Examination Center, Kyoto, Japan.
  • Nosaka K; Department of Hematology, Kumamoto University of Medicine, Kumamoto, Japan.
  • Uchimaru K; Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.
  • Iwanaga M; Department of Hematology and Oncology, Research Hospital, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Sagara Y; Department of Frontier Life Science, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Yamano Y; Japanese Red Cross Kyushu Block Blood Center, Fukuoka, Japan.
  • Okayama A; Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki, Japan.
  • Miura K; Department of Rheumatology, Infectious Diseases and Laboratory Medicine, University of Miyazaki, Miyazaki, Japan.
  • Satake M; Department of Obstetrics and Gynecology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Saito S; Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan.
  • Watanabe T; Department of Obstetrics and Gynecology, University of Toyama, Toyama, Japan.
  • Hamaguchi I; Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.
Microbiol Immunol ; 62(10): 673-676, 2018 Oct.
Article em En | MEDLINE | ID: mdl-30125970
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: DNA Viral / Vírus Linfotrópico T Tipo 1 Humano / Leucemia de Células T / Reação em Cadeia da Polimerase em Tempo Real Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Microbiol Immunol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: DNA Viral / Vírus Linfotrópico T Tipo 1 Humano / Leucemia de Células T / Reação em Cadeia da Polimerase em Tempo Real Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Microbiol Immunol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão